Updated consensus statement on the use of rituximab in patients with rheumatoid arthritis
Academic Article
Publication Date:
2011
Iris type:
1.1 Articolo in rivista
Keywords:
Antibodies, Monoclonal, Murine-Derived; Antirheumatic Agents; Arthritis, Rheumatoid; Drug Administration Schedule; Drug Therapy, Combination; Evidence-Based Medicine; Glucocorticoids; Humans; Randomized Controlled Trials as Topic; Rituximab; Treatment Outcome; Rheumatology; Immunology and Allergy; Immunology; Biochemistry, Genetics and Molecular Biology (all)
List of contributors:
Buch, Maya H.; Smolen, Josef S.; Betteridge, Neil; Breedveld, Ferdinand C.; Burmester, Gerd; Dörner, Thomas; Ferraccioli, Gianfranco; Gottenberg, Jacques-Eric; Isaacs, John; Kvien, Tore K.; Mariette, Xavier; Martin-Mola, Emilio; Pavelka, Karel; Tak, Paul P.; Van Der Heijde, Desiree; Van Vollenhoven, Ronald F.; Emery, ; Paul Carbonell Abello, J; Bukhari, M; Burkhardt, H; Combe, B; Gomez-Reino Carnota, Jj; Barile Fabris, L; Klareskog, L; Marenco de la Fuente, Jl; Montecucco, C; Mikkel, Ostergaard; Pascual Gomez, E; Sanmarti Sala, R; Tony, Hp; Valesini, G; van Laar, J; van Riel, P.
Published in: